CIK 0001574094 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
RenovoRx, Inc.
Sign in to watch- Ticker
- RNXT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 271448452
- Phone
- 408-800-2649
- Business address
- 2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW, CA, 94040
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 7,500 shares at $0.91 ($6,821)
- 4 Open-market buy Chief Medical Officer bought 20,000 shares at $0.80 ($16,000)
- 4 Open-market buy VP Controller and PAO bought 12,595 shares at an average $0.79 ($10,011)
- 4 Open-market buy Chief Medical Officer bought 30,000 shares at $0.81 ($24,399)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $0.83 ($8,300)
- 4 Open-market buy Director bought 12,050 shares at $0.85 ($10,218)
- 4 Open-market buy Chief Medical Officer bought 26,000 shares at $0.84 ($21,840)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $0.83 ($8,300)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Medical Officer bought 40,983 shares
- 4 Open-market buy Director bought 40,983 shares
Page 3 of 6 · 111 filings